Task Force 6: Clinical Considerations for the Care of Competitive Athletes with Congenital Heart Disease
Athletes with congenital heart disease are commonly restricted from competitive sports participation based on limited data regarding exercise-induced sudden cardiac death risk. For most athletes, the myriad of benefits derived from participating in competitive sports outweighs the risk. This document reviews the cardiac assessment that may be considered for children, adolescents, and young adults with congenital heart disease. By utilizing anatomy, physiology, symptoms, and cardiac testing, together with shared decision-making, the authors propose a strategy to help guide medical providers advising their patients on sports participation.
Authors
- Keri M. Shafer (ORCID: https://orcid.org/0000-0002-6447-1843)
- Peter N. Dean (ORCID: https://orcid.org/0000-0002-9279-5415)
- Jonathan H. Kim (ORCID: https://orcid.org/0000-0001-5885-0284)
- Aaron Leigh Baggish (ORCID: https://orcid.org/0000-0003-2042-1489)
- Julie A. Brothers
- SILVANA MOLOSSI
- BENJAMIN D. LEVINE
Institutions
- Children's Hospital of Philadelphia (US)
- Emory University (US)
- Baylor College of Medicine (US)
- Centre Hospitalier Universitaire Vaudois (CH)
- Texas Children's Hospital (US)
- University of Virginia (US)
- University of Pennsylvania (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Medicine & Science in Sports & Exercise
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1249/mss.0000000000004094
- Primary Topic
- Cardiovascular Effects of Exercise
- Type
- article
- Field-Weighted Citation Impact
- 0.00